Nantong Jinghua Pharmaceutical Co Ltd (002349) — Financial Flexibility Index
Nantong Jinghua Pharmaceutical Co Ltd (002349) has a Financial Flexibility Index of 0.26x as of September 2025. Free cash flow of CN¥102.55 Million (operating CF CN¥97.93 Million minus capex CN¥4.62 Million) represents 0% of total liabilities (CN¥393.50 Million). Check cash flow reinvestment rate of Nantong Jinghua Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nantong Jinghua Pharmaceutical Co Ltd Financial Flexibility Index (2006–2025)
Historical Financial Flexibility Index trend for Nantong Jinghua Pharmaceutical Co Ltd across 20 annual periods. For the full cash flow conversion analysis, see 002349 operating cash flow.
Annual Financial Flexibility Index for Nantong Jinghua Pharmaceutical Co Ltd (2006–2025)
Year-by-year free cash flow to debt coverage for Nantong Jinghua Pharmaceutical Co Ltd. Explore 002349 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.86x | CN¥361.19 Million | CN¥340.87 Million | CN¥421.13 Million | ▼ -13.6% |
| 2024 | 0.99x | CN¥341.94 Million | CN¥311.02 Million | CN¥344.66 Million | ▲ +18.2% |
| 2023 | 0.84x | CN¥319.69 Million | CN¥291.31 Million | CN¥380.75 Million | ▼ -16.4% |
| 2022 | 1.00x | CN¥419.98 Million | CN¥358.39 Million | CN¥417.93 Million | ▲ +63.6% |
| 2021 | 0.61x | CN¥386.12 Million | CN¥305.57 Million | CN¥628.54 Million | ▼ -8.0% |
| 2020 | 0.67x | CN¥446.68 Million | CN¥328.22 Million | CN¥669.29 Million | ▼ -2.0% |
| 2019 | 0.68x | CN¥540.73 Million | CN¥285.38 Million | CN¥793.62 Million | ▲ +97.2% |
| 2018 | 0.35x | CN¥243.68 Million | CN¥83.43 Million | CN¥705.27 Million | ▼ -60.3% |
| 2017 | 0.87x | CN¥517.10 Million | CN¥75.92 Million | CN¥594.47 Million | ▼ -66.3% |
| 2016 | 2.58x | CN¥588.90 Million | CN¥343.80 Million | CN¥227.87 Million | ▲ +4193.1% |
| 2015 | -0.06x | CN¥-17.19 Million | CN¥-76.01 Million | CN¥272.27 Million | ▼ -129.8% |
| 2014 | 0.21x | CN¥74.54 Million | CN¥45.70 Million | CN¥351.96 Million | ▲ +2499.7% |
| 2013 | 0.01x | CN¥2.68 Million | CN¥-54.94 Million | CN¥328.99 Million | ▼ -99.3% |
| 2012 | 1.10x | CN¥267.51 Million | CN¥77.25 Million | CN¥242.84 Million | ▲ +11.6% |
| 2011 | 0.99x | CN¥142.33 Million | CN¥41.45 Million | CN¥144.23 Million | ▼ -14.1% |
| 2010 | 1.15x | CN¥76.95 Million | CN¥41.06 Million | CN¥66.96 Million | ▲ +53.9% |
| 2009 | 0.75x | CN¥62.16 Million | CN¥57.76 Million | CN¥83.26 Million | ▲ +196.1% |
| 2008 | 0.25x | CN¥19.49 Million | CN¥17.13 Million | CN¥77.29 Million | ▼ -28.7% |
| 2007 | 0.35x | CN¥38.31 Million | CN¥33.86 Million | CN¥108.25 Million | ▲ +80.5% |
| 2006 | 0.20x | CN¥25.13 Million | CN¥22.18 Million | CN¥128.18 Million | — |